Cargando…
Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
BACKGROUND: Alzheimer’s disease (AD) is the most common cause of dementia and most of AD patients suffer from vascular abnormalities and neuroinflammation. There is an urgent need to develop novel blood biomarkers capable of diagnosing Alzheimer’s disease (AD) at very early stage. This study was per...
Autores principales: | Park, Jung Eun, Lim, Do Sung, Cho, Yeong Hee, Choi, Kyu Yeong, Lee, Jang Jae, Kim, Byeong C., Lee, Kun Ho, Lee, Jung Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796542/ https://www.ncbi.nlm.nih.gov/pubmed/33422144 http://dx.doi.org/10.1186/s40364-020-00258-5 |
Ejemplares similares
-
Diagnostic Blood Biomarkers in Alzheimer’s Disease
por: Park, Jung Eun, et al.
Publicado: (2022) -
High-throughput epitope profiling of antibodies in the plasma of Alzheimer’s disease patients using random peptide microarrays
por: Sim, Kyu-Young, et al.
Publicado: (2019) -
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019) -
Effect of 7-Methylsulfinylheptyl Isothiocyanate on the Inhibition of Melanogenesis in B16-F1 Cells
por: Kim, A-Ju, et al.
Publicado: (2021) -
Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry
por: Kim, Yeongshin, et al.
Publicado: (2022)